Clinical Trials Browser

Hypotension × Clear all

NCT07481851 2026-03-19

Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients

Hypotension, Urologic Neoplasms

NCT05738603 2025-08-03

The Hypotension Prediction Index in Free Flap Transplant in Head and Neck Surgery.

Phase NA Recruiting

Head and Neck Neoplasms, Hypotension, Postoperative Complications

NCT06953193 2025-05-01

Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia

Phase NA Recruiting

Gastrointestinal

Hypotension, Pancreatic Neoplasms, Postoperative Complications

NCT02004834 2024-12-06

Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine

Phase 4 Active not recruiting

Bradycardia, Breast Neoplasms, Hypotension

NCT02018497 2023-09-21

ESSENTIAL

Atrial Fibrillation, Autonomic Nervous System Diseases, Ischemic Attack, Transient, Cerebrovascular Disorders, Coronary Disease, Depression, Diabetes Mellitus, Fibromyalgia, Hypotension, Neoplasms, Syncope, Fatigue Syndrome, Chronic, Panic Disorder, Syncope, Vasovagal, Acute Coronary Syndrome, Heart Failure, Systolic, Heart Failure, Diastolic

NCT05354661 2022-05-31

Perioperative Hypotension in Gynaecologic Oncologic Surgery: HPI-ClearSight Versus Arterial Waveform Analysis

Hypotension

NCT03215797 2018-01-23

Phenylephrine or Norepinephrine for a Better Hemodynamic Stability

Phase 3 Completed

Hypotension

NCT02811406 2016-06-23

The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites

Phase NA Unknown

Ascites, Hypotension

NCT01593579 2014-12-23

Autonomic Phenotype Before and After Akt Inhibition

Hypotension, Melanoma, Pure Autonomic Failure

NCT01418118 2011-08-16

Free4Flow

Phase 4 Completed

Head and Neck Neoplasms, Hypotension, Mouth Neoplasms

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Phase 4 Completed

Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

NCT00033956 2005-06-24

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

Phase 1/2 Suspended

DermatologicGenitourinary

Carcinoma, Renal Cell, Hypotension, Melanoma